Hyundai Pharm Sells Dementia Drug in Hypertension Packs
MFDS Advises "Stop Medication If Suspicious"

Hyundai Pharm recorded a 52-week low following news that dementia medication was distributed in containers meant for hypertension treatment drugs.


Hyundai Minoxidil Tablets (left) and Tamirin Sustained-Release Tablets 8 mg [Photo by Ministry of Food and Drug Safety]

Hyundai Minoxidil Tablets (left) and Tamirin Sustained-Release Tablets 8 mg [Photo by Ministry of Food and Drug Safety]

View original image

On the 3rd, as of 11 a.m., Hyundai Pharm was trading at 3,940 KRW, down 4.37% from the previous trading day. Early in the session, the stock fell as much as 6.55% to 3,850 KRW, marking a 52-week low. It is understood that the recent revelation that Hyundai Pharm sold dementia treatment drugs in hypertension medication containers affected the stock price.


Earlier, on the 1st, the Ministry of Food and Drug Safety announced that Hyundai Pharm was voluntarily recalling the Hyundai Minoxidil Tablets 30-count product (product number 23018) produced on the 15th of last month. 'Minoxidil' is used as a hypertension treatment and for hair loss, but during distribution, an issue occurred where the container for this drug contained 'Tamirin Tablets,' an Alzheimer's dementia treatment.


In response, Hyundai Pharm initiated an urgent recall, and approximately 20,000 bottles have been retrieved. However, it is reported that no consumers have mistakenly taken the wrong medication due to this issue.


The two drugs are produced on the same production line and have similar size and shape, which is believed to have caused this error. On the same day, the Ministry of Food and Drug Safety stated, "This labeling error involved attaching the label of 'Hyundai Minoxidil Tablets' (hypertension treatment) to the packaging container of 'Tamirin Sustained Release Tablets 8mg' (dementia treatment) 30-count. It has been confirmed that the two drugs were not mixed in the packaging."



The ministry added, "If there is suspicion of receiving Tamirin Sustained Release Tablets 8mg during the dispensing process of Hyundai Minoxidil Tablets or upon consumption, please immediately stop taking the medication and return it to the purchasing pharmacy or Hyundai Pharm."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing